Google Alert - hepatitis c

[Guest guest]

News

6 new results for hepatitis c

Vertex Bests Merck in New Hepatitis C Drug SalesNew York Times (blog)By ANDREW POLLACK Updated: 4:45 pm In the closely watched bout between two new hepatitis C drugs, it's a knockout in the first round. Vertex Pharmaceuticals' Incivek, trumped the rival drug Victrelis from Merck in third-quarter sales. ...See all stories on this topic »

Research and Markets: Hepatitis C - Pipeline Review, H2 2011SunHerald.com'Hepatitis C - Pipeline Review, H2 2011', provides an overview of the Hepatitis C therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis C, complete with latest updates, and special features on late-stage ...See all stories on this topic »

NDG needle exchange program cancelledMontreal GazetteStreetwork, a program started in 2006 and run by health and social services provider Head and Hands, employed two full-time employees to distribute needles, crack pipes and condoms to cut the risk of contracting HIV and hepatitis C. In August, ...See all stories on this topic »

Carling Clinic Probe To Cost $750000, Internal City MemoPosted on Oct 28, 2011Ottawa Citizen (blog)Therefore, the Medical Officer of Health was statutorily obligated to assess, develop and implement a response to address the very low risk that patients and secondary contacts in the community were exposed to Hepatitis B virus, Hepatitis C virus, ...See all stories on this topic »

CERVANTES v. HEALTH PLAN OF NEVADA, INC.Leagle.comBy the Court, DOUGLAS, J. Appellant Margerita Cervantes allegedly contracted hepatitis C as a result of treatments she received at the Endoscopy Center of Southern Nevada (ECSN). She obtained treatment at ECSN as part of the health care benefits she ...See all stories on this topic »

Merck 3Q Net Soars From Weakened Prior YearWall Street JournalMerck reported $31 million in third-quarter sales of its new hepatitis-C drug Victrelis. In contrast, Vertex Pharmaceuticals Inc. (VRTX) on Thursday reported $420 million in sales of a rival new drug, Incivek. Merck's Schechter said Victrelis held ...See all stories on this topic »

- more news

http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/